Optimising adherence and QoL in metastatic NSCLC

Epidermal growth factor receptor tyrosine kinase inhibitors are widely used in the management of metastatic non-small cell lung cancer. Adverse events, their impact on quality of life and treatment adherence with these oral drugs are discussed
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: Featured Articles Source Type: news